Literature Search

Ailawadhi(S),Hansen(DK),Dhakal(B),Shune(LO),… Adv Ther 2026-05-00

...cel (cilta-cel) was approved in February 2022 for adults with relapsed/refractory multiple myeloma (RRMM). This study ev...

Gregory(T),De Braganca(KC),Alegria(V),Percia… Cancers (Basel) 2026-02-26

...cel (cilta-cel) for relapsed/refractory multiple myeloma is typically administered inpatient (IP) to monitor for cytokin...

Hou(F),Yang(L),Liu(J),Li(Q),Zhou(H),Li(G) Animals (Basel) 2026-02-25

...cellulose (MIX2), CON diet diluted with 0.5% of inulin and 1.5% of cellulose (MIX3), and CON diet diluted with 2.0% of c...

Zhang(S),Zhang(M),Zhang(B),Li(N),Chen(L) Bioorg Med Chem Lett 2026-07-00

Celastrol (CEL), a natural product, has attracted great attention because of its remarkable antitumor potential. Its uni...

Nabil(GM),Althomali(RH),Elsyed(M) Int J Biol Macromol 2026-04-00

...cellulose (Cel). This was extensively characterized by diverse instrumentations to affirm the incorporated functional gr...

Yang(J),Wang(X),Bai(X),Deng(R),Ye(W),Liu(Q),… Front Pharmacol None

...Cel on anoikis resistant TNBC cells (TNBC-AR) cells, including MDA-MB-231-AR cells and BT-549-AR cells. Using CCK-8 and ...

Janakiram(M),Fan(L),Ghosh(S),Alegria(V),Perc… J Med Econ 2026-12-00

...cel (cilta-cel) has demonstrated remarkable efficacy in relapsed or refractory multiple myeloma (RRMM). Outpatient (OP) ...

Tai(W),Chaudhry(F),Shahrour(N),Thomas(J),Any… Cureus 2026-02-00

...cell therapy with lisocabtagene maraleucel (liso-cel). Given his post-transplant status, his immunosuppressive agents (t...

Kuhnl(A),Kirkwood(AA),Northend(M),Besley(C),… Hemasphere 2026-02-00

...cel (axi-cel) as second-line (2 L) treatment for large B-cell lymphoma (LBCL), results from real-world CAR T cohorts wil...

Farid(KMN),Kocher(F),Arnold(T),Fauser(J),Hen… Blood Adv 2026-06-09

...cel (tab-cel) is an allogeneic Epstein-Barr virus (EBV)-specific T-cell therapy approved in the European Union for relap...